K. Hellmann
Impact in
- Oncology top 5%
- Cancer Treatment and Pharmacology
- Toxicology top 5%
Papers in ⓘ
- Oncology 24
- Cancer Treatment and Pharmacology 13
- Colorectal Cancer Treatments and Studies 7
-
- Cancer therapeutics and mechanisms 7
- Co-authors
- Rosemary I. Hawkins (6 shared papers)E.O. Field (3 shared papers)A. J. Salsbury (4 shared papers)A. M. Creighton (1 shared paper)J. S. Weiner (3 shared papers)D. F. Tucker (4 shared papers)V J Ferrans (2 shared papers)Erik Herman (2 shared papers)
- Journals
- Nature (11 papers)Clinical & Experimental Metastasis (9 papers)The Journal of Physiology (5 papers)The Lancet (5 papers)Cancer (4 papers)
- Partner nations
- United KingdomUnited StatesCanada
In The Last Decade
K. Hellmann
99 papers receiving 2.0k citations
Peers
Comparison fields: 5 of 137
- Oncology 724
- Toxicology 59
- Cardiology and Cardiovascular Medicine 330
- Cancer Research 213
- Dermatology 110
Countries citing papers authored by K. Hellmann
This map shows the geographic impact of K. Hellmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K. Hellmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K. Hellmann more than expected).
Fields of papers citing papers by K. Hellmann
This network shows the impact of papers produced by K. Hellmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K. Hellmann. The network helps show where K. Hellmann may publish in the future.
Co-authors
The 25 scholars most cited alongside K. Hellmann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 102 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1968 | 168 | |
| 2 | 1969 | 138 | |
| 3 | 1998 | 131 | |
| 4 | 1972 | 113 | |
| 5 | 1969 | 84 | |
| 6 | 1970 | 76 | |
| 7 | 1965 | 72 | |
| 8 | 1970 | 72 | |
| 9 | 1960 | 64 | |
| 10 | 1982 | 59 | |
| 11 | Histological analysis of the antimetastatic effect of (plus or minus)-1,2-bis(3,5-dioxopiperazin-1-yl)propane. | 1974 | 54 |
| 12 | 1965 | 50 | |
| 13 | 1953 | 50 | |
| 14 | 1955 | 48 | |
| 15 | 1991 | 47 | |
| 16 | 1969 | 43 | |
| 17 | 1974 | 40 | |
| 18 | 1964 | 40 | |
| 19 | Fundamentals of cancer chemotherapy | 1987 | 39 |
| 20 | 1966 | 37 |
About K. Hellmann
K. Hellmann is a scholar working on Oncology, Molecular Biology, Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging and Surgery, having authored 102 papers that have together received 2.2k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (13 papers), Lung Cancer Treatments and Mutations (9 papers), Cancer therapeutics and mechanisms (7 papers), Colorectal Cancer Treatments and Studies (7 papers), Chemotherapy-induced cardiotoxicity and mitigation (6 papers), Radiopharmaceutical Chemistry and Applications (5 papers), Cancer, Hypoxia, and Metabolism (5 papers) and Multiple Myeloma Research and Treatments (4 papers). The work is most often cited by research in Oncology (724 citations), Toxicology (59 citations), Cardiology and Cardiovascular Medicine (330 citations), Cancer Research (213 citations) and Dermatology (110 citations). K. Hellmann has collaborated with scholars based in United Kingdom, United States and Canada. Frequent co-authors include Rosemary I. Hawkins, E.O. Field, A. J. Salsbury, A. M. Creighton, J. S. Weiner, D. F. Tucker, V J Ferrans, Erik Herman, Brian B. Hasinoff and H. Blaschko. Their work appears in journals such as Nature, Clinical & Experimental Metastasis, The Journal of Physiology, The Lancet and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.